These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5705788)

  • 1. Chromosomes of benign and malignant lesions of the breast.
    Toews HA; Katayama KP; Masukawa T; Lewison EF
    Cancer; 1968 Dec; 22(6):1296-307. PubMed ID: 5705788
    [No Abstract]   [Full Text] [Related]  

  • 2. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
    Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
    Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome analysis in 31 cases of benign and malignant breast tumors: a study in Brazil.
    Benetti MR; Kessler RG; Bittelbrunn AC; Frantz B; Biazus JV; Giugliani R
    Hereditas; 2002; 137(1):57-64. PubMed ID: 12564633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation profiling of benign and malignant breast lesions and its application to cytopathology.
    Pu RT; Laitala LE; Alli PM; Fackler MJ; Sukumar S; Clark DP
    Mod Pathol; 2003 Nov; 16(11):1095-101. PubMed ID: 14614048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.
    André F; Michiels S; Dessen P; Scott V; Suciu V; Uzan C; Lazar V; Lacroix L; Vassal G; Spielmann M; Vielh P; Delaloge S
    Lancet Oncol; 2009 Apr; 10(4):381-90. PubMed ID: 19249242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of alterations in chromosomes 16 and 1 by fluorescence in situ hybridization in breast tumors cytologically or histologically equivocal for malignancy.
    Tsuda H; Takarabe T; Shimamura K; Hirohashi S
    Pathobiology; 1998; 66(6):268-73. PubMed ID: 9769473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
    Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
    Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of numerical aberrations of specific chromosomes by fluorescent in situ hybridization as a diagnostic tool in breast cancer.
    Ichikawa D; Hashimoto N; Hoshima M; Yamaguchi T; Sawai K; Nakamura Y; Takahashi T; Abe T; Inazawa J
    Cancer; 1996 May; 77(10):2064-9. PubMed ID: 8640671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of breast cancer cell lines.
    Davidson JM; Gorringe KL; Chin SF; Orsetti B; Besret C; Courtay-Cahen C; Roberts I; Theillet C; Caldas C; Edwards PA
    Br J Cancer; 2000 Nov; 83(10):1309-17. PubMed ID: 11044355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual chromosomes and malignant disease.
    Merz T; el-Mahdi AM; Prempree T
    Lancet; 1968 Feb; 1(7538):337-9. PubMed ID: 4170166
    [No Abstract]   [Full Text] [Related]  

  • 11. Male breast cancer. 3. Breast carcinoma in association with the Klinefelter syndrome.
    Scheike O; Visfeldt J; Petersen B
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):352-8. PubMed ID: 4767227
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetic evaluation of 20 primary breast carcinomas.
    Cavalli LR; Cavaliéri LM; Ribeiro LA; Cavalli IJ; Silveira R; Rogatto SR
    Hereditas; 1997; 126(3):261-8. PubMed ID: 9350140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomes in malignant gynaecological effusions.
    Olinici CD; Galatir N; Lazarov P; Giurgiuman M
    Neoplasma; 1973; 20(3):311-24. PubMed ID: 4725517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
    Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of primary and metastatic breast carcinoma defined by fluorescence in situ hybridization.
    Simpson JF; Quan DE; Ho JP; Slovak ML
    Am J Pathol; 1996 Sep; 149(3):751-8. PubMed ID: 8780379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions.
    Costa MJ; Tadros T; Hilton G; Birdsong G
    Acta Cytol; 1993; 37(4):461-71. PubMed ID: 8328240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.
    Euhus DM; Maitra A; Wistuba II; Alberts A; Albores-Saavedra J; Gazdar AF
    J Surg Res; 1999 May; 83(1):13-8. PubMed ID: 10210636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative expression of the LINE-1 p40 protein in human breast carcinomas and normal breast tissues.
    Asch HL; Eliacin E; Fanning TG; Connolly JL; Bratthauer G; Asch BB
    Oncol Res; 1996; 8(6):239-47. PubMed ID: 8895199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subclinical breast lesions manifested by microcalcifications. Historadiologic correlations. Apropos of a retrospective series of 127 cases].
    Avigdor S; Lebas P; du Rouchet E; Lansac J; Body G
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):365-72. PubMed ID: 8051362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary lesions of the breast: a molecular progression?
    Di Cristofano C; Mrad K; Zavaglia K; Bertacca G; Aretini P; Cipollini G; Bevilacqua G; Ben Romdhane K; Cavazzana A
    Breast Cancer Res Treat; 2005 Mar; 90(1):71-6. PubMed ID: 15770529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.